This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, C. Articles by Lin, R.-J. Search for Related Content PubMed PubMed Citation Articles by Li, C. Articles by Lin, R.-J.

Cell Type and Culture Condition–Dependent Alternative Splicing in Human Breast Cancer Cells Revealed by Splicing-Sensitive Microarrays

¹ City of Hope Graduate School of Biological Sciences; Divisions of ² Molecular Biology and ³ Immunology, Beckman Research Institute of City of Hope, Duarte, California; and ⁴ Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, California

Requests for reprints: Ren-Jang Lin, Division of Molecular Biology, Beckman Research Institute of City of Hope, 1450 East Duarte Road, Duarte, CA 91010. Phone: 626-301-8286; Fax: 626-301-8280; E-mail: rlin{at}coh.org.

Growing evidence indicates that alternative or aberrant pre-mRNA splicing takes place during the development, progression, and metastasis of breast cancer. However, which splicing changes that might contribute directly to tumorigenesis or cancer progression remain to be elucidated. We used splicing-sensitive microarrays to detect differences in alternative splicing between two breast cancer cell lines, MCF7 (estrogen receptor positive) and MDA-MB-231 (estrogen receptor negative), as well as cultured human mammary epithelial cells. Several splicing alterations in genes, including CD44, FAS, RBM9, hnRNPA/B, APLP2, and MYL6, were detected by the microarray and verified by reverse transcription-PCR. We also compared splicing in these breast cancer cells cultured in either two-dimensional flat dishes or in three-dimensional Matrigel conditions. Only a subset of the splicing differences that distinguish MCF7 cells from MDA-MB-231 cells under two-dimensional culture condition is retained under three-dimensional conditions, suggesting that alternative splicing events are influenced by the geometry of the culture conditions of these cells. Further characterization of splicing patterns of several genes in MCF7 cells grown in Matrigel and in xenograft in nude mice shows that splicing is similar under both conditions. Thus, our oligonucleotide microarray can effectively detect changes in alternative splicing in different cells or in the same cells grown in different environments. Our findings also illustrate the potential for understanding gene expression with resolution of alternative splicing in the study of breast cancer. (Cancer Res 2006; 66(4): 1990-9)

This article has been cited by other articles:

				J. P. Venables, R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, et al. Identification of Alternative Splicing Markers for Breast Cancer Cancer Res., November 15, 2008; 68(22): 9525 - 9531. [Abstract] [Full Text] [PDF]

				K. Fushimi, P. Ray, A. Kar, L. Wang, L. C. Sutherland, and J. Y. Wu Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5 PNAS, October 14, 2008; 105(41): 15708 - 15713. [Abstract] [Full Text] [PDF]

				J. P. Venables, C.-S. Koh, U. Froehlich, E. Lapointe, S. Couture, L. Inkel, A. Bramard, E. R. Paquet, V. Watier, M. Durand, et al. Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins Mol. Cell. Biol., October 1, 2008; 28(19): 6033 - 6043. [Abstract] [Full Text] [PDF]

				Y. Arvidsson, E. Andersson, A. Bergstrom, M. K Andersson, G. Altiparmak, A.-C. Illerskog, H. Ahlman, D. Lamazhapova, and O. Nilsson Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract Endocr. Relat. Cancer, June 1, 2008; 15(2): 569 - 581. [Abstract] [Full Text] [PDF]

				L. Shkreta, U. Froehlich, E. R. Paquet, J. Toutant, S. A. Elela, and B. Chabot Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes Mol. Cancer Ther., June 1, 2008; 7(6): 1398 - 1409. [Abstract] [Full Text] [PDF]

				R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, J. Gervais-Bird, R. Madden, E. R. Paquet, C. Koh, J. P. Venables, P. Prinos, et al. Multiple Alternative Splicing Markers for Ovarian Cancer Cancer Res., February 1, 2008; 68(3): 657 - 663. [Abstract] [Full Text] [PDF]

				M. J. Moore and P. A. Silver Global analysis of mRNA splicing RNA, February 1, 2008; 14(2): 197 - 203. [Abstract] [Full Text] [PDF]

				C. Ben-Dov, B. Hartmann, J. Lundgren, and J. Valcarcel Genome-wide Analysis of Alternative Pre-mRNA Splicing J. Biol. Chem., January 18, 2008; 283(3): 1229 - 1233. [Abstract] [Full Text] [PDF]

				V. Filippov, M. Filippova, and P. J. Duerksen-Hughes The Early Response to DNA Damage Can Lead to Activation of Alternative Splicing Activity Resulting in CD44 Splice Pattern Changes Cancer Res., August 15, 2007; 67(16): 7621 - 7630. [Abstract] [Full Text] [PDF]

				N. J. Camp, J. M. Farnham, and L. A. Cannon-Albright Localization of a Prostate Cancer Predisposition Gene to an 880-kb Region on Chromosome 22q12.3 in Utah High-Risk Pedigrees. Cancer Res., October 15, 2006; 66(20): 10205 - 10212. [Abstract] [Full Text] [PDF]

				A. Srebrow and A. R. Kornblihtt The connection between splicing and cancer J. Cell Sci., July 1, 2006; 119(13): 2635 - 2641. [Abstract] [Full Text] [PDF]